Company Profile
Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
API-Alanyl glutamine |
L-Glutamine,L-alanyl-;L-Glutamine,N2-L-alanyl-;Glutamine,N2-L-alanyl-;L-Alanyl-L-glutamine;Dipeptiven;Dipeptamin;L-Ala-L-Gln;72: PN: US20070066537 PAGE: 17 claimed protein;GlutaMAX;Glutamax I;Alanyl-glutamine;96: PN: WO2011146121 PAGE: 115 claimed sequence;Sustamine;63: PN: WO2020097235 SEQID: 292 claimed protein |
39537-23-0 | - / 99% | Inquiry |
API-Dextran 40 |
Dextran;Dextrans;Dextran 40;Dextran 45;Dextran 70;Dextran 75;Dextran 110;Dextran 150;Dextranen;Dextran PVD;Dextran RMI;Dextraven;Expandex;Gentran;Intrader;Macrose;Onkotin;Plavolex;Rheotran;Polyglucin;Dextran 60;Dextran 10;Infucoll;Macrodex;Rheomacrodex;Dextran D 10;Dextran 15;Plasmodex;Hemodex;Rheopolyglucine;α-Dextran;Dextran T 150;Dextran 500;LMD;LMWD;LVD;Eudextran;Rheodextran;Dextran T 10;Intradex;Rheoisodex;Plasmafusin;T 70;Dextran 1000;Dextran T 500;Dextran T 110;Dextran 2000;Rheopolyglucin;Dextran B1355;Dextran T 2000;Hyskon;Promit;Ultradex;LU 122;Dextran T 70;Dextran 3000;Rondex;Rondex (polysaccharide);Rheorondex;Polyglusol;Dextran T 20;T 150;T 500;T 10 (carbohydrate);T 500 (carbohydrate);T 10;T 20;T 110;T 250;T 20 (carbohydrate);T 110 (carbohydrate);Dextran B 512;Dextran PT 25;Dextran 1.5;T 40 (polysaccharide);T 40;DEX 500;Dextran PL 1S;PL 1S;Dextran 250;Serva G;Hyscon;T 250 (polysaccharide);T 70 (carbohydrate);Longasteril 70;Oncovertin N;G 75;Dextran 40000;Dextran 10000;Dextran 20000;T 4 (polysaccharide);T 5 (polysaccharide);T 4;T 5;Dextran T 40;Dextran T 100;Gentran 40;Detrax 40;T 6;R-gel;D 9260;D 1390;Dextran D 9260;Dextran D 1390;D 5376;9013-80-3;9044-66-0;11104-36-2;11121-03-2;12626-85-6;37224-17-2;60454-72-0;86280-85-5;128635-03-0;911319-01-2;1307300-43-1;1415795-13-9 |
9004-54-0 | - / 99% | Inquiry |
API-Epalrestat |
3-Thiazolidineacetic acid,5-[(2E)-2-methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-,(5Z)-;3-Thiazolidineacetic acid,5-(2-methyl-3-phenyl-2-propenylidene)-4-oxo-2-thioxo-,(Z,E)-;3-Thiazolidineacetic acid,5-[(2E)-2-methyl-3-phenyl-2-propenylidene]-4-oxo-2-thioxo-,(5Z)-;(5Z)-5-[(2E)-2-Methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-3-thiazolidineacetic acid;ONO 2235;Epalrestat;Kinedak;Sorbistat;Eabeth;2-[(Z)-5-((E)-2-Methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl]acetic acid;125654-73-1 |
82159-09-9 | - / 99% | Inquiry |
API-Gadodiamide |
Gadolinium,[5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]-;Gadolinium,[5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)]-;2,5,8,11-Tetraazatridecan-13-oic acid,5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-,gadolinium complex;[5,8-Bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]gadolinium;S 041;Gadolinium-DTPA-BMA;Gd DTPA-BMA;Gadodiamide;DV 7572 |
131410-48-5 | - / 99% | Inquiry |
API-Iopromide |
1,3-Benzenedicarboxamide,N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl-;1,3-Benzenedicarboxamide,N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl-;N1,N3-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl-1,3-benzenedicarboxamide;Iopromide;SHL 414C;Ultravist;Ultravist 370;Ultravist 300;ZK 35760;Iopromidum;1-N,3-N-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-N-methylbenzene-1,3-dicarboxamide |
73334-07-3 | - / 99% | Inquiry |
API-L(-)-Malic acid |
Butanedioic acid,2-hydroxy-,(2S)-;Malic acid,L-;Butanedioic acid,hydroxy-,(S)-;Butanedioic acid,hydroxy-,(2S)-;Malic acid,l-;(2S)-2-Hydroxybutanedioic acid;Apple acid;(-)-Hydroxysuccinic acid;(-)-Malic acid;L-Malic acid;L-(-)-Malic acid;(S)-Malic acid;S-(-)-Malic acid;(-)-(S)-Malic acid;S-2-Hydroxybutanedioic acid;(-)-L-Malic acid;NSC 9232;(2S)-2-Hydroxysuccinic acid;L-Apple acid;(2S)-Malic acid;(S)-2-Hydroxysuccinic acid;(2S)-2-Hydroxysuccinic acid;(2S)-2-Hydroxybutanedioic acid;124501-05-9;498-37-3;6294-10-6;84781-39-5 |
97-67-6 | - / 99% | Inquiry |
API-Moxifloxacin Hydrochloride |
3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-,hydrochloride (1:1);3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-,monohydrochloride,(4aS-cis)-;3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-,monohydrochloride;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1);Moxifloxacin hydrochloride;BAY 12-8039;Avalox;Avelox;Octegra;Lapinix;Actira;Avelonm |
186826-86-8 | - / 99% | Inquiry |
API-Moxonidine |
5-Pyrimidinamine,4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-;4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine;BE 5895;Moxonidine;BDF 5895;2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline;Cynt;Lomox;Moxon;Normoxocin;Physiotens;LY 326869;Nucynt;Norcynt;Moxogamma;(4-Chloro-6-methoxy-2-methyl-pyrimidin-5-yl)-imidazolidin-2-ylidene-amine;257301-50-1 |
75438-57-2 | - / 99% | Inquiry |
API-Tirofiban hydrochloride |
L-Tyrosine,N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-,hydrochloride (1:1);L-Tyrosine,N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-,monohydrochloride;MK 383;N-(Butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-L-tyrosine hydrochloride;Tirofiban hydrochloride;L 700462;Aggrastat |
142373-60-2 | - / 99% | Inquiry |
API-Ubenimex |
L-Leucine,N-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-;L-Leucine,N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-,[S-(R*,S*)]-;N-[(2S,3R)-3-Amino-2-hydroxy-1-oxo-4-phenylbutyl]-L-leucine;Bestatin;NK 421;Ubenimex;(-)-Bestatin;NSC 265489;339186-55-9 |
58970-76-6 | - / 99% | Inquiry |